X-irradiation enhances in vitro human immunodeficiency virus replication correlation with cellular levels of cAMP.
Total body x-irradiation has been utilized in the treatment of several human diseases, including leukemia, where it is followed by bone marrow transplantation, and in some autoimmune disorders. Recently, it was reported that total body irradiation appeared useful in the treatment of Friend leukemia virus infection in mice. In this report, the effect of x-irradiation on the replication of human immunodeficiency virus (HIV) in vitro in CD4+ cells was examined. MT-4 cells and HIV strain human T cell lymphotropic virus Type IIIB were used to conduct this study. Infected MT-4 cells were irradiated at the time of infection or following infection with x-ray doses of 25-300 cGy. Doses of 50, 150, and 300 cGy enhanced HIV replication by 1.6-, 2-, and 4.8-fold, respectively. Irradiating the cells prior to infection also resulted in similar enhancement of HIV replication. This phenomenon was also observed with wild-type HIV isolates grown in peripheral blood mononuclear and in HIV chronically infected cells. In addition, the enhancement was associated with a radiation-induced increase in intracellular levels of cAMP. The use of the cAMP-dependent protein kinase A inhibitor, H-8, inhibited HIV replication by 65%. These data suggest that in vitro exposure to low doses of x-ray enhances HIV replication partially via a cAMP-dependent pathway.
Department of Internal Medicine, University of Texas Medical Branch, Galveston 77550.
M
M
Nokta
J
J
Belli
R
R
Pollard
D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism / Q000382:microbiology; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism*; D004307:Dose-Response Relationship, Radiation; D006678:HIV / Q000502:physiology* / Q000528:radiation effects; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000378:metabolism / Q000382:microbiology; D047428:Protein Kinase Inhibitors; D014779:Virus Replication / Q000528:radiation effects*
D007546:Isoquinolines; D047428:Protein Kinase Inhibitors; C053177:N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide; D000242:Cyclic AMP